The American Diabetes Association’s (ADA) 82nd Scientific Sessions is almost here! From June 3-7, scientists and healthcare professionals will gather—in person!—at one of the largest conferences of diabetes researchers in the world. Breakthrough T1D researchers and Breakthrough T1D-funded scientists will also be there virtually to hear first-hand and present new study results that will improve outcomes for people with diabetes (T1D). Read what’s happening below.
ADA’s 82nd Scientific Sessions
- The Scientific Sessions is one of the largest gatherings of diabetes researchers in the world, where scientists and healthcare professionals share and learn about new diabetes advances with top experts.
- JDRF-supported research has been highlighted at this annual event since Breakthrough T1D started funding research, showcasing new breakthroughs and therapies for people with T1D.
- This year, researchers will present 120+ studies—with Breakthrough T1D-funding at present or in the past—encompassing breakthrough clinical trials and significant research studies that are paving the way to novel and emerging treatments for T1D.
- JDRF-funded researchers will outline new advances like:
Curing T1D
- Cell Therapies
- What are the latest advances in stem cell-derived replacement approaches?
- Disease-Modifying Therapies
- What role does innate immunity have in type 1?
- Generating new beta cells in the body: True or false?
- T1D Screening
- General vs. targeted screening: Which one is best?
Improving Lives
- Glucose Control
- What are the benefits of artificial pancreas systems in real time?
- How close are we to “smart” insulin?
- Complications
- Diabetic kidney disease breakthroughs: Are we ready?
- A new Breakthrough T1D staging system for diabetic eye disease: Are we ready for prime time?
- Psychosocial
- How do we prevent disparities in T1D intervention and treatment?
Throughout the Scientific Sessions, Breakthrough T1D will be sharing updates to keep people apprised of the day-to-day happenings:
- Blog posts before, during, and after the ADA meeting
- A Facebook Live event (@myJDRF) for each day, taking place the following day from 12:00 p.m. CT, with Breakthrough T1D-funded scientists talking about the takeaways
- A “happy hour” with CEO Aaron J. Kowalski, Ph.D., from 7-8 p.m. ET on Tuesday, June 7, speaking about the takeaways from the ADA Scientific Sessions and a Q&A period to answer questions from you, via Facebook Live (@myJDRF)
- Interviews with Breakthrough T1D-funded scientists, who will go over their research and what it means to the T1D community, to be pushed out on social media
- To stay updated, follow us on Facebook (@myJDRF) and Twitter (@JDRF and @JDRFResearch), with the hashtags #JDRFxADA and #ADA2022
